@EmmaStone 6 days ago
Moderna soars 179% on melanoma vaccine news Post:
Moderna soars 179% on melanoma vaccine news Post:
exploded higher after positive melanoma treatment data sent investors rushing back into the biotech name.
The move shows just how dramatically successful clinical results can change the outlook for a biotech company, especially as Moderna looks to build a future beyond COVID vaccines.
Do you think can hold onto these gains, or was the rally too extreme?
@Ethancollins 5 days ago
The clinical data is definitely encouraging, but biotech rallies can get ahead of themselves quickly. The key question is whether future trial results continue to support the long-term growth story.
@IsabelLynn 5 days ago
it is really great to see moderna moving into areas outside of the pandemic. hopefully the clinical trials keep showing these kinds of results for patients.
